Eliem Therapeutics Financial Health
How is Eliem Therapeutics's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: ELYM's short term assets ($133.2M) exceed its short term liabilities ($6.3M).
Long Term Liabilities: ELYM's short term assets ($133.2M) exceed its long term liabilities ($219.0K).
Debt to Equity History and Analysis
Debt Level: ELYM is debt free.
Reducing Debt: ELYM has not had any debt for past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ELYM has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: ELYM has sufficient cash runway for 2.1 years if free cash flow continues to reduce at historical rates of 53.4% each year.